I’m Running 10 Marathons This Year And I Still Get Fat-Shamed. Here’s My Response.
Mind your business ― keep your eyes off of my scale and your imagination off of my plate.
Related Articles
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort – PubMed
NCT02834013 (registered 15 July, 2016; https://clinicaltrials.gov/ct2/show/NCT02834013).
Pattern and the Medical College of Wisconsin Launch New Pilot Study to Assess Detection of Head, Neck and Lung Cancers Through ProSpectral™ Saliva Analysis
REDMOND, Wash., Aug. 21, 2024 (GLOBE NEWSWIRE) — Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Pattern and the Medical College of Wisconsin…
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series
KRAS wild-type (WT) pancreatic ductal adenocarcinoma (PDAC) represents a distinct entity with unique biology. The therapeutic impact of matched targeted therapy in these patients in…
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series
KRAS wild-type (WT) pancreatic ductal adenocarcinoma (PDAC) represents a distinct entity with unique biology. The therapeutic impact of matched targeted therapy in these patients in…
Outpatient Administration of CAR T-cell Therapies Using a Strategy of No Remote Monitoring and Early CRS Intervention – PubMed
Recent studies demonstrating the feasibility of outpatient chimeric antigen receptor modified (CAR) T-cell therapy administration are either restricted to CARs with 41BB costimulatory domains or…
Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs: A Systematic Review and Meta-analysis – PubMed
Many studies suggest a survival benefit for cancer trial participants. However, these benefits were not detected in studies using designs addressing important sources of bias…
Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses
Many diseases can have similar genetic changes to those seen in cancer. This review summarizes these genetic changes along with cancer drugs that have benefit…
Former UCLA oncologist awarded $14 million in retried gender discrimination case – Daily Bruin
The Los Angeles Superior Court awarded $14 million to a former UCLA oncologist Thursday following an eight-year battle over her gender discrimination lawsuit. Dr. Lauren…
Former UCLA oncologist awarded $14 million in retried gender discrimination case – Daily Bruin
The Los Angeles Superior Court awarded $14 million to a former UCLA oncologist Thursday following an eight-year battle over her gender discrimination lawsuit. Dr. Lauren…
High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy
Immunology; Molecular biology; Cancer